NeoMatrix Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
25 Health Sciences Dr Ste 124, Stony Bro...Phone Number
(631) 241-4964Website
www.neomatrixtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NeoMatrix Therapeutics
NeoMatrix Therapeutics, Inc. is a clinical-stage company focused on developing novel therapeutic agents for serious burn injuries. The company specializes in bioactive peptides that aim to prevent injury progression, enhance healing, and improve patient outcomes. Their lead candidates, NMT-cP12 and NMT-cNP8, are designed to treat severe burns and have shown promise in clinical trials. NeoMatrix Therapeutics targets first responders and civilian victims, with applications extending beyond burns to various tissue injuries.Explore more
NeoMatrix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeoMatrix Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NeoMatrix Therapeutics is spiking on competitors!
Click to see if NeoMatrix Therapeutics had a recent Job posting/layoffs
NeoMatrix Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NeoMatrix Therapeutics
Funding: Get notified immidiatlly once NeoMatrix Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when NeoMatrix Therapeutics launches new products
Earning: See what the market has to say on NeoMatrix Therapeutics recently announced quarterly report
Check if NeoMatrix Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined NeoMatrix Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to NeoMatrix Therapeutics
Compare insights from companies similar to NeoMatrix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NeoMatrix Therapeutics
<$5M
1-10
Private
<$5M
1996
CS
Caron ShakeChief Operating Officer & Government Liaison
Company Profile Activity
Activity Insights
NeoMatrix Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeoMatrix Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeoMatrix Therapeutics.
NeoMatrix Therapeutics financials insights
Gather financial insights about NeoMatrix Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$33K
NeoMatrix Therapeutics Tech Stack
A closer look at the technologies used by NeoMatrix Therapeutics
NeoMatrix Therapeutics News & Media
NeoMatrix Therapeutics (NMT) Peptide Discovery Advances Treatment of Burn Injury - Novel Peptide Progresses to Phase 2
Novel Peptide Progresses to Phase 2 for the Treatment of Severe Burns STONY BROOK, NY, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- NeoMatrix Therapeutics, Inc., a clinical-stage company focused on developing a portfolio of novel, bioactive …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeoMatrix Therapeutics
Sign Up For FreeTo access detailed company insights
NeoMatrix Therapeutics, Inc. is a clinical-stage company focused on developing novel therapeutic agents for serious burn injuries. The company specializes in bioactive peptides that aim to prevent injury progression, enhance healing, and improve patient outcomes. Their lead candidates, NMT-cP12 and NMT-cNP8, are designed to treat severe burns and h... Read More
